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Dunnet’s test. * indicates significant difference from control 
(without inhibitor) (p < 0.05). 
   
Figure 4.20 Effect of vanillin, syringaldehyde and p-hydroxybenzaldehyde on 
p-NP glucuronidation in RKM. The reaction was performed in the 
presence of p-NP (0.5 mM), RKM (0.125 mg mL
-1
) at five 
different concentrations of oil palm EFB lignin. Each bar 
represents the mean percentage activity relative to negative 
control ± SD for five replicates (n=5). Statistical analysis was 
conducted using one-way ANOVA followed by Dunnet’s test. * 
indicates significant difference from control (without inhibitor) (p 
< 0.05). 
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Figure 4.21 Inhibition of p-NP glucuronidation in RLM by vanillin and 
syringaldehyde compared to positive inhibitor (diclofenac). Data 
are expressed as the mean percentage activity relative to negative 
control ± SD for five replicates (n=5). Error bars represent two-
sided standard error of the mean. Data points were fitted to IC50 
equation as described under Materials and Methods. Goodness of 
fit R
2
 values were greater than 0.9. 
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syringaldehyde compared to positive inhibitor (diclofenac). Data 
are expressed as the mean percentage activity relative to negative 
control ± SD for five replicates (n=5). Error bars represent two-
sided standard error of the mean. Data points were fitted to IC50 
equation as described under Materials and Methods. Goodness of 
fit R
2
 values were greater than 0.9. 
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Figure 4.23 Effect of soda, kraft and organosolv on p-NP glucuronidation by 
in vivo treatment in RLM. Rats were treated with 0, 40 and 400 
mg kg
-1
 of soda, kraft and organosolv oil palm EFB lignin for 14 
days before sacrifice. Each bar represents the mean percentage 
activity relative to control ± SD for five replicates (n=5). 
Statistical analysis was conducted using one-way ANOVA 
followed by Dunnet’s test. * indicates significant difference from 
control (received co-solvent) (p < 0.05). 
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Figure 4.24 Effect of soda, kraft and organosolv on p-NP glucuronidation by 
in vivo treatment in RKM. Rats were treated with 0, 40 and 400 
mg kg
-1
 of soda, kraft and organosolv oil palm EFB lignin for 14 
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days before sacrifice. Each bar represents the mean percentage 
activity relative to control ± SD for five replicates (n=5). 
Statistical analysis was conducted using one-way ANOVA 
followed by Dunnet’s test. * indicates significant difference from 
control (received co-solvent) (p < 0.05). 
   
Figure 4.25 HPLC analysis of 4-MU glucuronidation in RLM and RKM. The 
method of sample preparation and the HPLC conditions are 
describe in Section 3.12.1 until 3.12.11. A) blank sample from 
RLM. The peak at 11.125 minute in A is 4-MU, B) incubation 
sample from RLM. The peak at 7.017 minute in B is 4-MUG and 
the peak at 11.142 minute is 4-MU, C) blank sample from RKM. 
The peak at 10.925 minute in C is 4-MU, D) incubation sample 
from RKM. The peak at 7.553 minute in D is 4-MUG and the 
peak at 11.125 minute is 4-MU 
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Figure 4.26 The effect of incubation time on 4-MU glucuronide formation in 
RLM and RKM. Reactions were performed in the presence of 4-
MU (0.1 mM) and RLM or RKM (0.25 mg mL
-1
) in a total 
volume incubation of 0.25 mL at 37 °C. Each point represents the 
mean 4-MU glucuronidated (4-MUG) (µM) values ± SD for 
triplicates (n=3). 
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Figure 4.27 The effect of RLM and RKM protein concentration on 4-MU 
glucuronide formation in RLM and RKM. Reactions were 
performed in the presence of 4-MU (0.1 mM) and RLM or RKM 
(0 to 1 mg mL
-1
) in a total volume incubation of 0.25 mL for 15 
minutes at 37 °C. Each point represents the mean 4-MU 
glucuronidated (4-MUG) (µM) values ± SD for triplicates 
measurement (n=3). 
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Figure 4.28 The effect of Triton X-100 concentration on 4-MU glucuronide 
formation in RLM and RKM. Reactions were performed in the 
presence of 4-MU (0.1 mM), RLM or RKM (0.125 mg mL
-1
) in a 
total volume incubation of 0.25 mL for 15 minutes at 37 °C. Each 
point represents the mean 4-MU glucuronidated (4-MUG) (µM) 
values ± SD for triplicates (n=3). 
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Figure 4.29 Michaelis-Menten plot for 4-MU glucuronidation in RLM and 
RKM, respectively. Each reaction (0.25 mL) was performed in 
the presence of RLM or RKM (0.125 mg mL
-1
) and 4-MU 
concentration range from 0.05 – 4.0 mM. Each point represents 
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the mean of nmol per minute per milligram of 4-MU glcuronide 
formed ± SD of three replicates (n=3).  
   
Figure 4.30 Effect of DMSO on 4-MU glucuronidation in RLM and RKM. 
The reaction was performed in the presence of 4-MU (0.1 mM), 
RLM or RKM (0.125 mg mL
-1
) at five different concentrations of 
DMSO. Each bar represents the mean percentage activity relative 
to control ± SD for five replicates (n=5). Statistical analysis was 
conducted using one-way ANOVA followed by Dunnet’s test. * 
indicates significant difference from control (without DMSO) (p 
< 0.05). 
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Figure 4.31 Effect of soda, kraft and organosolv on 4-MU glucuronidation in 
RLM. The reaction was performed in the presence of 4-MU (0.1 
mM), RLM (0.125 mg mL
-1
) at six different concentrations (0.01, 
0.1, 1.0, 10, 100 and 500 µg mL
-1
) of oil palm EFB lignin. Each 
bar represents the mean percentage activity relative to control ± 
SD for three replicates (n=3). Statistical analysis was conducted 
using one-way ANOVA followed by Dunnet’s test. * indicates 
significant difference from control (without inhibitor) (p < 0.05). 
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Figure 4.32
  
Inhibition of 4-MU glucuronidation in RLM by soda, kraft and 
organosolv oil palm EFB lignin compared to positive inhibitor 
(diclofenac). Data are expressed as the mean percentage activity 
relative to negative control ± SD for three replicates (n=3). Error 
bars represent two-sided standard error of the mean. Data points 
were fitted to IC50 equation as described under Materials and 
Methods. Goodness of fit R
2
 values were greater than 0.9. 
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Figure 4.33 Effect of soda, kraft and organosolv on 4-MU glucuronidation in 
RKM. The reaction was performed in the presence of 4-MU (0.1 
mM), RKM (0.125 mg mL
-1
) at five different concentrations 
(0.01, 0.1, 1.0, 10 and 100 µg mL
-1
) 
 
of oil palm EFB lignin. Each 
bar represents the mean percentage activity relative to control ± 
SD for three replicates (n=3). Statistical analysis was conducted 
using one-way ANOVA followed by Dunnet’s test. * indicates 
significant difference from control (without inhibitor) (p < 0.05). 
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Figure 4.34 Inhibition of 4-MU glucuronidation in RKM by soda, kraft and 
organosolv oil palm EFB lignin compared to positive inhibitor 
(diclofenac). Data are expressed as the mean percentage activity 
relative to negative control ± SD for three replicates (n=3). Error 
bars represent two-sided standard error of the mean. Data points 
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were fitted to IC50 equation as described under Materials and 
Methods. Goodness of fit R
2
 values were greater than 0.9. 
   
Figure 4.35 Effect of vanillin, syringaldehyde and p-hydroxybenzaldehyde on 
4-MU glucuronidation in RLM. The reaction was performed in 
the presence of 4-MU (0.1 mM), RLM (0.125 mg mL
-1
) at six 
different concentrations (0.01, 0.1, 1.0, 10, 100 and 500 µM) of 
compounds. Each bar represents the mean percentage activity 
relative to control ± SD for three replicates (n=3). Statistical 
analysis was conducted using one-way ANOVA followed by 
Dunnet’s test. * indicates significant difference from control 
(without inhibitor) (p < 0.05). 
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MU glucuronidation in RKM. The reaction was performed in the 
presence of 4-MU (0.1 mM), RKM (0.125 mg mL
-1
) at five different 
concentrations (0.01, 0.1, 1.0, 10, 100 and 500 µM) of compounds. 
Each bar represents the mean percentage activity relative to control ± 
SD for three replicates (n=3). Statistical analysis was conducted using 
one-way ANOVA followed by Dunnet’s test. * indicates significant 
difference from control (without inhibitor) (p < 0.05). 
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Figure 4.37 Inhibition of 4-MU glucuronidation in RLM by vanillin and 
syringaldehyde compared to positive inhibitor (diclofenac). Data 
are expressed as the mean percentage activity relative to negative 
control ± SD for three replicates (n=3). Error bars represent two-
sided standard error of the mean. Data points were fitted to IC50 
equation as described under Materials and Methods. Goodness of 
fit R
2
 values were greater than 0.9. 
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Figure 4.38 Inhibition of 4-MU glucuronidation in RKM by vanillin and 
syringaldehyde compared to positive inhibitor (diclofenac). Data 
are expressed as the mean percentage activity relative to negative 
control ± SD for three replicates (n=3). Error bars represent two-
sided standard error of the mean. Data points were fitted to IC50 
equation as described under Materials and Methods. Goodness of 
fit R
2
 values were greater than 0.9. 
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Figure 4.39 Lineweaver-Burk plots of inhibition of UGT-catalyzed 4-MU 
glucuronidation by soda oil palm EFB lignin. Data are expressed 
as the mean to control ± SD for three replicates (n=3). Error bars 
represent two-sided standard error of the mean. Goodness of fit 
R
2
 values were greater than 0.9. 
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Figure 4.40 Secondary plots of UGT activity using the slopes of the primary 
Lineweaver-Burk plots versus the concentrations of soda oil palm 
EFB lignin. Each data point represents an average ± SD of 
triplicates (n=3). Error bars represent two-sided standard error of 
the mean. Goodness of fit R
2
 values were greater than 0.990. 
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Figure 4.41 Effect of soda, kraft and organosolv on 4-MU glucuronidation by 
in vivo treatment in RLM. Rats were treated with 0, 40 and 400 
mg kg
-1
 of soda, kraft and organosolv oil palm EFB lignin for 14 
days before sacrifice. Each bar represents the mean percentage 
activity relative to control ± SD for three replicates (n=3). 
Statistical analysis was conducted using one-way ANOVA 
followed by Dunnet’s test. * indicates significant difference from 
control (received co-solvent) (p < 0.05). 
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in vivo treatment in RKM. Rats were treated with 0, 40 and 400 
mg kg
-1
 of soda, kraft and organosolv oil palm EFB lignin for 14 
days before sacrifice. Each bar represents the mean percentage 
activity relative to control ± SD for three replicates (n=3). 
Statistical analysis was conducted using one-way ANOVA 
followed by Dunnet’s test. * indicates significant difference from 
control (received co-solvent) (p < 0.05). 
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RLM treated with 400 mg kg
-1
 of oil palm EFB lignin compared 
to control (received co-solvent). The glucuronidation rates 
represent the mean of three replicates (n=3) with vertical error 
bars indicating two sided standard error of the mean. Goodness of 
fit R
2
 values were greater than 0.9.   
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Figure 4.44 Michaelis-Menten kinetics plots for 4-MU glucuronidation in 
RKM treated with 400 mg kg
-1
 of oil palm EFB lignin compared 
to control (received co-solvent). The glucuronidation rates 
represent the mean of three replicates (n=3) with vertical error 
bars indicating two sided standard error of the mean. Goodness of 
fit R
2
 values were greater than 0.9.   
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Figure 4.45 Optimization of incubation time. The conjugation reaction of 1-
chloro-dinitrobenzene (CDNB) catalyzed by GST enzyme in RLC 
and RKC was performed in the total incubation volume of 300 µL 
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in the presence of 1-chloro-dinitroenzene (CDNB) (1mM) as a 
substrate for GST enzyme and the rat liver cytosolic fraction 
(RLC) or rat kidney cytosolic fraction (RKC) (0.125 mg mL
-1
) for 
0 – 5 minutes reaction time. Each point represents the absorbance 
of dinitrobenze-glutathione conjugate formed in various time 
incubation ± SD for five replicates (n=5). 
   
Figure 4.46 Optimization of protein concentration. The conjugation reaction 
of 1-chloro-dinitrobenzene (CDNB) catalyzed by GST enzyme in 
RLC and RKC was performed in the total incubation volume of 
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as a substrate for GST enzyme and the rat liver cytosolic fraction 
(RLC) or rat kidney cytosolic fraction (RKC) (0.0625 – 1.0 mg 
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-1
) for 5 minutes reaction time. Each point represents the 
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-1
) 
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Figure 4.48 Effect of DMSO on GST enzyme activity in RLC and RKC. The 
reaction was performed in the presence of CDNB (1.0 mM), RLC 
or RKC (0.125 mg mL
-1
) at five different concentrations of 
DMSO. Each bar represents the mean percentage activity relative 
to control ± SD for five replicates (n=5). Statistical analysis was 
conducted using one-way ANOVA followed by Dunnet’s test. * 
indicates significant difference from control (without DMSO) (p 
< 0.05). 
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Figure 4.49 Effect of soda, kraft and organosolv oil palm EFB lignin on GST 
enzyme activity in RLC. The reaction was performed in the 
presence of CDNB (1.0 mM), RLC (0.125 mg mL
-1
) at six 
different concentrations (0.01, 0.1, 1.0, 10, 50 and 100 µg mL
-1
) 
of oil palm EFB lignin. Each bar represents the mean percentage 
activity relative to control ± SD for five replicates (n=5). 
Statistical analysis was conducted using one-way ANOVA 
followed by Dunnet’s test. * indicates significant difference from 
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control (without inhibitor) (p < 0.05). 
   
Figure 4.50 Inhibitory effect of soda, kraft and organosolv compare to 
positive inhibitor (tannic acid) on CDNB conjugation reaction 
catalyzed by the GST enzyme from RLC. Concentration of 
inhibitors ranged from 0.01 – 100 µg mL-1. Data are expressed as 
the mean percentage activity relative to negative control ± SD for 
five replicates (n=5). Error bars represent two-sided standard 
error of the mean. Data points were fitted to IC50 equation as 
described under Materials and Methods. Goodness of fit R
2
 values 
were greater than 0.9. 
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enzyme activity in RKC. The reaction was performed in the 
presence of CDNB (1.0 mM), RKC (0.125 mg mL
-1
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different concentrations (0.01, 0.1, 1.0, 10, 50 and 100 µg mL
-1
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of oil palm EFB lignin. Each bar represents the mean percentage 
activity relative to control ± SD for five replicates (n=5). 
Statistical analysis was conducted using one-way ANOVA 
followed by Dunnet’s test. * indicates significant difference from 
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2
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analysis was conducted using one-way ANOVA followed by 
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(without inhibitor) (p < 0.05). 
168 
   
Figure 4.54 Effect of vanillin, syringaldehyde and p-hydroxybenzaldehyde on 
GST enzyme activity in RKC. The reaction was performed in the 
169 
xxv 
 
presence of CDNB (1.0 mM), RKC (0.125 mg mL
-1
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different concentrations (0.01, 0.1, 1.0, 10, 50 and 100 µM) of 
compounds. Each bar represents the mean percentage activity 
relative to control ± SD for five replicates (n=5). Statistical 
analysis was conducted using one-way ANOVA followed by 
Dunnet’s test. * indicates significant difference from control 
(without inhibitor) (p < 0.05). 
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-1
 of soda, kraft and organosolv oil palm EFB lignin for 14 
days before sacrifice. Each bar represents the mean percentage 
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Statistical analysis was conducted using one-way ANOVA 
followed by Dunnet’s test. * indicates significant difference from 
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PENILAIAN TERHADAP LIGNIN TANDAN KOSONG KELAPA SAWIT 
PADA METABOLISME DRUG FASA II YANG TERPILIH 
 
 
ABSTRAK 
Dalam usaha untuk membangunkan lignin tandan kosong kelapa sawit 
(TKKS) sebagai makanan tambahan dalam nutraseutikal dan kesihatan, penyelidikan 
tentang potensinya dalam berinteraksi dengan drug lain melalui perencatan atau 
peningkatan enzim metabolisme drug (DME) mampu memastikan keselamatan 
produk. Oleh itu, kajian ini dijalankan untuk mengkaji kesan lignin TKKS dan 
sebatian-sebatian teroksida utamanya terhadap DME fasa II UDP-
glukuronosiltransferase (UGT) dalam mikrosom hati tikus (RLM) dan mikrosom 
ginjal tikus (RKM) serta glutation S-transferase (GST) dalam fraksi sitosol hati tikus 
(RLC) dan fraksi sitosol ginjal tikus (RKC) secara rawatan in vitro dan in vivo. 
Pencirian lignin TKKS menunjukkan bahawa ketiga-tiga jenis ekstrak lignin TKKS 
(soda, kraft dan organosolv) terdiri daripada siringil dan guaiasil. Jumlah kandungan 
flavonoid pada lignin TKKS meningkat dalam turutan organosolv < kraft < soda. 
Analisis kromatografi cecair berprestasi tinggi (HPLC) menunjukkan bahawa 
siringaldehid merupakan sebatian teroksida utama yang terdapat dalam lignin TKKS 
diikuti dengan vanilin dan p-hidroksibenzaldehid. lignin TKKS dinilai sebagai aktiviti 
penghapus radikal bebas DPPH yang berpotensi. Keputusan kajian menunjukkan 
lignin dengan kandungan kumpulan fenolik (ArOH) yang tinggi, jisim molar (Mw) 
yang rendah dan poliserakan (Mw/Mn) yang kecil menunjukkan aktiviti penghapus 
radikal bebas DPPH yang tinggi. p-nitrofenol (p-NP) dan 4-metilumbelliferon (4-
MU) masing-masing digunakan sebagai substrat prob dalam asai UGT, manakala 1-
kloro-2,4-dinitrobenzena (CDNB) digunakan sebagai substrat prob dalam asai GST. 
xxxi 
 
Bagi perawatan in vitro, potensi perencatan lignin TKKS bagi kedua-dua 
glukuronidasi p-NP dan 4-MU dalam RLM dan RKM dipengaruhi oleh kandungan 
flavonoidnya (soda > kraft > organosolv). Potensi perencatan juga dipengaruhi oleh 
kehadiran vanilin dalam ekstrak lignin. Bagi aktiviti enzim GST, potensi perencatan 
lignin TKKS dalam RLC dan RKC juga dipengaruhi oleh kandungan flavonoidnya 
(soda > kraft > organosolv). Walau bagaimanapun, potensi perencatan lignin TKKS 
terhadap aktiviti enzim GST dalam kedua-dua RLC dan RKC tidak dipengaruhi oleh 
sebatian-sebatian teroksida utamanya. Bagi rawatan in vivo, dos rendah (40 mg kg
-1
) 
lignin TKKS mengurangkan glukuronidasi p-NP dan 4-MU dalam kedua-dua RLM 
dan RKM. Manakala, dos tinggi (400 mg kg
-1
) lignin TKKS meningkatkan 
glukuronidasi p-NP dan 4-MU dalam kedua-dua RLM dan RKM. Bagi aktiviti enzim 
GST dalam RLC dan RKC, kedua-dua dos meningkatkan aktiviti enzim. Keputusan 
juga menunjukkan kandungan flavonoid lignin TKKS berkemungkinan 
bertanggungjawab terhadap peningkatan aktiviti GST yang diperhatikan. 
Kesimpulannya, kajian ini mencadangkan lignin TKKS boleh memberi kesan 
terhadap konjugasi substrat oleh enzim yang melibatkan enzim UGT1A6 dan enzim 
GST kelas µ- terutamanya dalam hati tikus.  
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AN EVALUATION OF OIL PALM EMPTY FRUIT BUNCH LIGNIN ON 
SELECTED PHASE II DRUG METABOLIZING ENZYMES 
 
 
ABSTRACT 
 
In order to develop oil palm empty fruit bunch (EFB) lignin as a nutraceutical 
and health supplement, the investigation of its potential in interacting with other 
drugs via inhibition or induction of drug metabolizing enzymes (DME) would 
contribute towards product safety. Therefore, this study was carried out to investigate 
the effect of oil palm EFB lignin and its main oxidative compounds on phase II DME, 
UDP-glucuronosyltranferases (UGT) in rat liver microsomes (RLM) and rat kidney 
microsomes (RKM) as well as glutathione-S-transferases (GST) in rat liver cytosolic 
fraction (RLC) and rat kidney cytosolic fraction (RKC) by in vitro and in vivo 
treatment. The characterization of oil palm EFB lignin showed that all three types of 
oil palm EFB lignin extracts (soda, kraft and organosolv) consist of syringyl and 
guaiacyl. The total flavonoids content of oil palm EFB lignin was increased in the 
order of organosolv < kraft < soda. The high performance liquid chromatography 
(HPLC) analysis revealed that syringaldehyde was the main oxidation compound in 
oil palm EFB lignin followed by vanillin and p-hydroxybenzaldehyde. The oil palm 
EFB lignin evaluated as potential DPPH-radical scavenging activity. Results 
indicated that the lignin with more phenolic group (ArOH) content, low molecular 
weight (Mw) and narrow polydispersity (Mw/Mn) showed high DPPH-radical 
scavenging activity. p-nitrophenol (p-NP) and 4-methylumbelliferone (4-MU) were 
employed as probe substrates in UGT assays, respectively, while 1-chloro-2,4-
dinitrobenzene (CDNB) was employed as probe substrate in GST assay. For in vitro 
treatment, the inhibitory potency of oil palm EFB lignin for both p-NP and 4-MU 
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glucuronidation in RLM and RKM were encouraged by its flavonoids content (soda > 
kraft > organosolv). The inhibitory potency was also encouraged by the presence of 
vanillin in the lignin extracts. For GST activity, the inhibitory potency of oil palm 
EFB lignin in RLC and RKC also encouraged by its flavonoids content (soda > kraft 
> organosolv). However, the inhibitory potency of oil palm EFB lignin on GST 
activity in both RLC and RKC was not encouraged by its main oxidation compounds. 
For in vivo treatment, the lower dosage (40 mg kg
-1
) of oil palm EFB lignin decreased 
the p-NP and 4-MU glucuronidation in both RLM and RKM. However, higher dosage 
(400 mg kg
-1
) of oil palm EFB lignin increased the p-NP and 4-MU glucuronidation 
in both RLM and RKM. For GST activity in RLC and RKC, both dosages increased 
the enzyme activity. Result also indicated that flavonoids content of oil palm EFB 
lignin might be responsible for the observed induction in GST activity. In conclusion, 
the findings suggest that oil palm EFB lignin may affect the conjugation of substrates 
by phase II enzymes which involved UGT1A6 and GST class µ- particularly in rat 
liver.  
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CHAPTER 1 
 
INTRODUCTION 
 
 
1.1 Background of the study  
Oil palm empty fruit bunch (EFB) lignin is known to be a good feedstock to 
produce biomaterial such as activated carbon (Fierro et al., 2006), fibre board 
(Velásquez et al., 2003), adhesives (Danielson and Simonson, 1998; Kouisni et al., 
2011), adsorbent (Mohamad Ibrahim et al., 2010a), bio-corrosion inhibitors 
(Akbarzadeh et al., 2011) and as filler in the formulation of inks, varnishes and 
paints (Belgacem et al., 2003). Besides, lignin which is extracted from 
lignocellulosic waste such as oil palm empty fruit bunch (EFB), sugar cane and 
wood has potential application in pharmaceutical and food product such as 
emulsifier (Mohamad Ibrahim 2010), antidiarrheal drug (Mitjans et al., 2001) and 
natural antioxidant (Dizhbite et al., 2004; Mitjans and Vinardell, 2005; Pan et al., 
2006; Ugartondo et al., 2008).  
Therefore, the various application of oil palm EFB lignin especially in 
pharmaceuticals and food products area give additional value to lignin. Usually, 
public believe that natural product can be equated to be safe. For this reason, they 
often self-prescribed without knowing its potentially dangerous implications. For 
example, the potential of the metabolic effect of herbals and phytochemicals on the 
efficacy and/or toxicity of drug, which is commonly reffered to as herb-drug 
interactions, which may lead to poor clinical outcomes, is one of the issues of 
concern to clinicians (Gardiner et al., 2008). The consequence of herb-drug 
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interactions can be beneficial effects such as cancer prevention, undesirable effects 
such as pharmacokinetics interactions with co-administered drugs and harmful 
effects; such as organ toxicity or carcinogenesis (Mandlekar et al., 2006).  
Since the development of the application of oil palm EFB lignin in 
pharmaceuticals and food products is growing nowadays, attention must also be 
given to the investigation of the effects of oil palm EFB lignin on the most important 
conjugative enzymes of phase II metabolism (UGT and GST). These enzymes 
mostly exhibit broad substrate selectivity and eliminate many therapeutic drugs, 
endogenous compounds and secondary plant metabolites such as flavonoids and 
polyphenolic compounds. In addition, the investigation of potential drug interaction 
with oil palm EFB lignin through competition with drugs for this conjugation 
pathway is needed to ensure consumer safety (Mohamed and Frye, 2011). 
The metabolism of xenobiotic (foreign compounds) and endogenous (internal 
compounds) is the body’s own detoxifying system which is crucial for its survival. 
Generally DMEs eliminate xenobiotics and endogenous substances by increasing 
solubility through the functionalization process in phase I and/or conjugation 
reactions in phase II. Phase I reactions involve oxidation, reduction and hydrolysis, 
where a functional group is exposed or introduced, usually resulting in a small 
increase in xenobiotic hydrophilicity and further prepare the xenobiotics for phase II 
(Gibson and Skett, 2001; Nassar, 2009). Phase II reactions involve conjugation 
reactions including conjugation with glutathione and other amino acids, 
glucuronidation, sulfation, acetylation and/or methylation. Therefore, phase II is the 
true ‘detoxification’ of both endogenous and foreign compounds to produce 
metabolites that are generally water-soluble and easily excreted. 
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Glucuronidation reaction involves conjugation of suitable functional groups 
on a substrate with glucuronic acid. This reaction, which requires UDP-glucuronic 
acid (UDPGA) as a co-factor, is catalyzed by the enzyme UDP-
glucuronosyltransferase (UGT). It is responsible for the elimination of structurally 
diverse xenobiotics and endogenous compounds (Miners and Mackenzie, 1991; 
Radominska-Pandya et al., 1999; Tukey and Strassburg, 2000). Glucuronidation 
serves as an elimination pathway in humans for numerous dietary chemicals, 
environmental pollution and endogenous compound such as bilirubin, bile acids and 
hydroxysteroid. Moreover, glucuronidation facilitates excretion of these compounds 
and the parent compounds in urine and bile as their hydrophilic conjugates and 
generally results in detoxification although a limited number of glucuronides possess 
biological activity (Ritter, 2000). In particular, glucuronidation is an essential 
clearance mechanism for drugs from all therapeutic classes. 
Another major phase II detoxification enzyme which is involved in the 
metabolism of xenobiotics and plays an important role in cellular protection against 
oxidative stress is glutathione S-transferase (GST) enzymes. GST plays a major role 
in the detoxification of epoxides derived from polycyclic aromatic hydrocarbons 
(PAHs) and alpha-beta unsaturated ketones. Moreover, a number of endogenous 
compounds such as prostaglandins and steroids are metabolized via glutathione 
conjugation (van Bladeren, 2000). The major biological function of glutathione 
transferase appears to be defence against reactive and toxic electrophiles such as 
reactive oxygen species (superoxide radical and hydrogen peroxide) that arise 
through normal metabolic processes.   
Therefore, this study was carried out to determine the effect of oil palm EFB 
lignin (soda, kraft and organosolv) and its main oxidative compounds (vanillin, 
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syringaldehyde and p-hydroxybenzaldehyde) on UGT and GST activity by in vitro 
and in vivo treatment. Rat liver microsomes (RLM) and rat kidney microsomes 
(RKM) were used as sources of the UGT enzyme, while rat liver cytosolic fraction 
(RLC) and rat kidneys cytosolic fraction (RKC) were used as the sources for GST 
enzymes. For UGT enzyme assay, para-nitrophenol (p-NP) and 4-
methylumbelliferone (4-MU) were used as substrates while 1-chloro-2,4-
dinitrobenzene (CDNB) was used as substrate for GST enzyme assay. 
Spectrophotometry and high performance liquid chromatography (HPLC) were the 
analytical methods used to evaluate the activities of the enzymes studied.  
 
1.2 Problem statement 
The development of oil palm EFB lignin for its application in 
pharmaceuticals and food industries promises an additional value to lignin. However, 
before oil palm EFB lignin can be developed as a nutraceutical and health 
supplement, the investigation of its potential in interacting with other drugs or 
pharmaceutical agents must be carry out to ensure product safety. This is because the 
oil palm EFB lignin would be metabolized by the same drug metabolism enzymes 
(DMEs) as other drugs or pharmaceutical agents. Therefore, it could results in food-
drug interaction and may cause adverse side effects (Honig et al., 1993; Sorensen, 
2002; Brandin et al., 2007). As an example, the inhibitory effect of drug 
metabolizing enzymes can cause harmful side effects such as increased plasma level 
and prolonged pharmacological effects of the parent drug and enhancement of drug 
induced toxicity (Hernandez and Rathinavelu, 2006; Gardiner et al., 2008).  
Given the importance of glucuronidation and glutathione conjugation as a 
detoxification and metabolic pathway for numerous xenobiotics and endogenous 
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compounds and the development of oil palm EFB lignin for pharmaceuticals and 
food industries applications, there is growing interest in the study of the potential for 
its interaction effect on phase II drug metabolism enzymes activity. In addition, the 
investigation of potential drug interaction with oil palm EFB lignin of drug 
metabolizing enzymes for this conjugation pathway is needed to ensure consumer 
safety. Therefore, to overcome the above problems, the aims of this study are:  
 
1) To characterize the oil palm EFB lignin etract of soda, kraft and organosolv 
via colorimetric (flavonoids content), chromatographic (gel permeation 
chromatography and high performance liquid chromatography) and 
spectroscopic (nuclear magnetic resonance) methods. 
2) To determine the correlation between 2,2-diphenyl-1-picrylhydrazyl (DPPH) 
radical scavenging activity of oil palm EFB lignin and its phenolic content, 
flavonoids content and molecular weight.  
3) To investigate the effect of oil palm EFB lignin etract of soda, kraft and 
organosolv and its main oxidative compounds (vanillin, syringaldehyde and 
p-hydroxybenzaldehyde) on UDP-glucuronosyltransferase (UGT) enzyme 
activity by in vitro and in vivo (sub-chronic) treatment using p-nitrophenol 
(p-NP) and 4-methylumbelliferone (4-MU), respectively as probe substrates 
in rat liver and kidney microsomes. Effect on p-NP is done using 
spectrophotometry method, while effect on 4-MU employed high 
performance liquid chromatography (HPLC) method. 
4) To evaluate the effect of oil palm EFB lignin extract of soda, kraft and 
organosolv and its main oxidative compounds (vanillin, syringaldehyde and 
p-hydroxybenzaldehyde) on glutathione S-transferase (GST) enzyme activity 
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by in vitro and in vivo (sub-chronic) treatment using 1-chloro-2,4-
dinitrobenzene (CDNB) as a probe substrate in rat liver and kidney cytosolic 
fraction, respectively.   
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CHAPTER 2 
 
LITERATURE REVIEW 
 
 
2.1 Oil palm empty fruit bunch 
 Based on the statistic shown by Malaysian Palm Oil Board (MPOB), 
Malaysia is second world’s leading producers of palm oil after Indonesia. The 
cultivation of mature and immature palm trees cover a total of 5.64 million hectres 
representing 52 % of the total area (10.9 million hectres) designated for agriculture 
and 17% of overall Malaysian territory (Ministry of Plantation Industries and 
Commodities, 2016). Simultaneously, cultivation also generates a substantial amount 
of lignocellulosic agriculture wastes. As far as oil palm is concerned, Malaysia has 
approximately 445 palm oil mills, processing about 97.57 million tons of fresh fruit 
bunch and producing an estimated 56 million tons of crop residue annually in the 
form of empty fruit bunch (EFB), fibres, trunks, fronds and shells (Malaysian Palm 
Oil Board, 2016). As one of the main exporter of palm oil in the world, utilization of 
oil palm biomass for the production of environmental-friendly biomaterials has 
become an attractive approach (Chew and Bhatia, 2008). Furthermore, the 
development of lignocellulosic industry is predicted to be an economy booster for 
small scale farmers. 
The oil palm empty fruit bunch (EFB) refers to a fiber residue formed after 
the oil palm fruits are separated from the bunches at palm oil mills using fruit 
shredders. The oil palm EFB is considered as non-hazardous biodegradable material 
as the fibres are clean, non-carcinogenic and free from pesticides and soft 
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parenchyma cells (Abdullah and Sulaiman, 2013). Oil palm EFB contained 
polymeric component such as hemicellulose (20-21 %), cellulose (35-40 %) and 
lignin (17-21 %) (Mohamad Ibrahim et al., 2010b). This renewable resource (oil 
palm EFB) as a raw material has been investigated by many researchers such as in 
polymer blended composite manufacturing (Rozman et al., 2004), the cellulose 
production (Umi Kalsom et al., 1997) and the production of various chemicals 
(Rahman et al., 2007). Furthermore, continuous studies by local researches had 
investigated the potential of oil palm EFB as a raw material in pulp and paper 
manufacturing as it is high in α-cellulose content (Khoo and Lee, 1991; Wan Rosli et 
al., 1998). Through its potential in the future pulp and paper industry, it can decrease 
the deforestation rate in the country. 
 However the pulping process also potentially produces effluent, namely black 
liquor. Irresponsible plant operators would simply drain the waste into the river as a 
way of disposing the black liquor. This will lead to situation of river sediment and 
cause water pollution. Therefore, this problem could be addressed through the 
recycling of black liquor to obtain lignin. The pulping process is considered special 
because it not only produces paper but it also recycles the black liquor to obtain a 
new product namely lignin. 
   
2.2 Oil palm empty fruit bunch lignin  
Lignin is a major cell wall component in plants (Figure 2.1). Lignin provides 
support for the plant, contributes to the transport of nutrients and water and protects 
against microorganisms (Buranov and Mazza, 2008). Lignin is an amorphous 
polymer built up by oxidative coupling of three major phenylpropanoid units namely 
trans-p-coumaryl alcohol, trans-coniferyl alcohol and trans-sinapyl alcohol (Lewis 
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and Yamamoto, 1990). The phenylpropanoids form a randomised structure in a 
three-dimensional network inside the cell wall as shown in the Figure 2.2. The 
phenylpropane units are commonly classified into three main types which differ in 
the amount of methoxyl groups namely p-hydroxyphenyl (H), guaiacyl (G) and 
syringyl (S) lignin (Lewis and Yamamoto, 1990). These basic units are primarily 
attached to different types of aryl-aryl ether type and have more than 10 different 
types of linkages (Brunow et al., 1999).  
 
 
 
 
 
  
 
 
 
 
Figure 2.1: Lignin position in vascular plant (Lewis and Yamamoto, 1990) 
 
 
 
 
 
 
 
Figure 2.2: Lignin consist of three major phenylpropanoid units which are (a) trans-p-
coumaryl alcohol, (b) trans-coniferyl alcohol and (c) trans-sinapyl alcohol (lewis and 
Yamamoto) 
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Oil palm empty fruit bunch (EFB) lignin is obtained from the pulping process 
of EFB. Generally, this process is accomplished by the digestion of EFB with 
sodium hydroxide (NaOH) for 3 hours at a pressure of 10 bars to separate the pulp 
and black liquor. The pulp can be processed into paper while the black liquor will be 
extracted with organic acid such as sulphuric acid (H2SO4) to obtain a precipitate. 
The precipitate will be filtered and the dried residue obtained will be the lignin (Wan 
Rosli et al., 1998). Figure 2.3 summarized the paper making process and lignin from 
EFB. Through the papermaking process, the EFB is used as a raw material, while the 
toxic waste namely, black liquor can be recycled to obtain lignin. There are three 
types of oil palm EFB lignin which were used in this study namely soda, kraft and 
organosolv. The different types of oil palm EFB lignin depend on the chemical and 
method which were used during pulping processes.   
The alkaline pulping process such as soda and kraft pulping is known as 
potential pulping process for non-woody materials (Feng and Alén, 2001; Garcia et 
al., 2009). Both of these pulping processes function to liberate lignin, hemicelluloses 
and cellulose to enhance the quality of the pulp (Wan Rosli et al., 1998). The kraft 
pulping is a dominant pulping process because it enables pulping of different tree 
species, recovers and reuses all pulping chemicals and produces a high quality paper. 
Kraft lignin contains several characteristic features distinguishing it from native 
lignin and other technical lignins. It contains an increased amount of phenolic 
hydroxyl groups due to extensive cleavage of β-aryl bonds during cooking (Prinsen 
et al., 2013).  
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Figure 2.3: Flowchart of the production of paper and lignin from oil palm empty fruit bunch 
Oil palm EFB Digestion process 
Pulp 
Paper Black liquor 
Lignin  
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However, there is a growing interest in applying soda pulping for non-woody 
based material in papermaking such as empty fruit bunch fibre (Wan Rosli et al., 
2004; Wan Rosli et al., 2005). The main difference of soda pulping compared to the 
kraft pulping is the sulphur-free medium of the cooking liquor (Gullischsen and 
Fogenholm, 2000). Soda lignin is sulphur-free; therefore, its chemical composition is 
closer to natural lignin compare to kraft lignin (Nadif et al., 2002; Wormeyer et al., 
2011). 
The organic pulping process such as organosolv pulping is also one of the 
most promising alternatives to existing pulping technologies. Lignin is separated via 
solubilization from organosolv pulping process. Solubilization makes it possible to 
obtain a less modified lignin. The properties of organosolv lignin differ from other 
technical lignins. The major features are low molecular weight and high chemical 
purity. Organosolv lignin is hydrophobic and show very poor solubility in water 
(Lora and Glasser, 2002). Organosolv pulping produces lignin of high quality, 
containing a lot of reactive side chains available for further chemical reactions 
(Meister, 2002).  
Organosolv lignin has been used as filler in the formulation of inks, varnishes 
and paints (Belgacem et al., 2003). Besides, organosolv lignin also can be used in the 
same applications as kraft and soda lignin. In addition, organosolv lignin could find 
valuable applications in the fields of adhesives, fibres, films and biodegradable 
polymers (Vasquez et al., 1999; Cetin and Ozmen, 2002; Pereira et al., 2007). 
Kraft lignin, which is produced from kraft pulping process has been 
successfully converted to activated carbon (Fierro et al., 2006) and is used to 
produce fibreboard (Velásquez et al., 2003). Kraft lignin has also been successfully 
formulated as adhesives especially in the formulation of lignin-phenol-formaldehyde 
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resins (Danielson and Simonson, 1998; Kouisni et al., 2011). Lignin is more readily 
available, less toxic and less expensive than phenol. Using kraft lignin to replace 
phenol in the formulation of phenol-formaldehyde resin is considered a potentially 
attractive application from the economic and ecological point of view because the 
phenol price is subjected to fluctuations in oil prices and supply and is generally 
lower than demand. 
Soda lignin which is produced from soda pulping process also has been 
successfully converted to biomaterial products such as adsorbent for heavy metals 
removal (Mohamad Ibrahim et al., 2010a), bio-corrosion inhibitors (Akbarzadeh et 
al., 2011). Soda lignin and phenol are structurally similar for possessing more 
phenolic hydroxyl groups. Therefore, soda lignin also has potential to be used as a 
substitute for part of the phenol in the synthesis of phenol-formaldehyde resin (Jin et 
al., 2010; Mohamad Ibrahim et al., 2011).   
 
2.3 The applications of lignin for pharmaceutical and food industry  
In addition to produce biomaterials products, lignin which is extracted from 
any lignocellulosic waste such as oil palm EFB, sugar cane, wood and others also 
has potential in pharmaceutical and food product industry. The application include as 
emulsifier (Mohamad Ibrahim, 2010), antidiarrheal drug (Mitjans et al., 2001) and 
natural antioxidant (Dizhbite et al., 2004; Mitjans and Vinardell, 2005; Pan et al., 
2006; Ugartondo et al., 2008).  
 
2.3.1 The potential of oil palm EFB lignin as an emulsifying agent for oil in 
water system emulsion   
 
Emulsions are thermodynamically unstable system because it is a 
hydrophobic colloid. While the contact between oil and water molecules is 
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energetically unfavourable, they tend to breakdown with time (Suzanne Nielsen, 
2010). There are two types of emulsion. The first type is oil-in-water (O/W) 
emulsion which is droplets of oil dispersed within water. This type of emulsion is 
applied in producing paints, detergents, ice cream and milk. The second type is 
water-in-oil (W/O) emulsion which is water droplets dispersed in oil. This system is 
widely used in food industry such as in producing of margarine, mayonnaise and 
cream (Mohamad Ibrahim, 2010). Since emulsion is not stable, it needs emulsifying 
agent or emulsifier to stabilize it by reducing the surface tensions between the oil and 
water phases (Suzanne Nielsen, 2010). 
An emulsifier is a surface-active molecule that absorbs to the surface of an 
emulsion droplet to form a protective coating that prevents the droplets from 
aggregating with one another. An emulsifier also reduces the interfacial tension and 
therefore facilitates the disruption of emulsion droplets during homogenization 
(Suzanne Nielsen, 2010). It consists of hydrophilic parts (water soluble) and 
lipophilic parts (oil soluble). When emulsifier is added to a mixture of water and oil, 
the hydrophilic end will bond with water while the lipophilic ends will bond with oil. 
In this way, the oil and water stay mixed together and this means that the emulsion is 
being stabilized (Mohamad Ibrahim, 2010). Although lignin does not form micelles, 
the molecule has both hydrophilic and lipophilic moieties (Gundersen and Sjöblom, 
1999). With these properties, oil palm EFB lignin can be applied as an emulsifying 
agent in pharmaceuticals and food product industries.  
A study by Mohamad Ibrahim (2010) has shown that the optimum percentage 
of emulsifier (oil palm EFB lignin) in the formulation of water in oil system is 16% 
(v/v). The mixture was homogenized by using a Silverson Laboratory Mixer 
Emulsifier for 2 minutes. The same procedures were repeated for the commercial 
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emulsifier (egg lecithin) and the performance of each formulation was compared. 
This investigation proved that oil palm EFB lignin has great potential as an 
emulsifying agent for oil in water system emulsion compared to the commercial 
emulsifying agent (egg lecithin). 
 
2.3.2 Lignin-based formulation (Ligmed-A) as antidiarrheal drug  
 The potential toxic effect of 4-days oral treatment with a lignin-based 
formulation (Ligmed-A) which is used to treat diarrhea in weaning pigs has been 
studied by Mitjans et al. (2001). Ligmed-A which was prepared from sugarcane, is 
composed of 90% lignin.  
Ligmed-A has been manufactured in Cuba since the 1990s and it shows 
similar efficacy to other drugs used to treat diarrhea (Fragas et al., 1997). However 
the oral administration of this compound may affect the activity of the small intestine 
and may damage mucous membranes, thereby reducing nutrient absorption. The 
study was carried out by daily oral dose of 2 g kg
-1
 of Ligmed-A to male Wistar 
albino (210 g) rats for 4 days which is the recommended dose and duration of 
administration in pigs. This study concluded that oral administration of Ligmed-A 
for 4 days did not affect mucosal sucrose, alkaline phosphatase activities or the 
morphometry of these three segments (duodenum, jejunum and ileum) in rats. The 
study also indicated that Ligmed-A could provide a potent antidiarrheal treatment in 
the veterinary area. 
 
2.3.3 Antioxidant properties of lignin  
 The antioxidant properties of natural substances as well as lignin with 
different origins have been of interest of many researchers in the past years 
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(Sakagami et al., 1992; Dizhbite et al., 2004; Mitjans and Vinardell, 2005; Pan et al., 
2006; Vinardell et al., 2008). Oxygen free radicals and other reactive oxygen species 
can cause oxidative injury to living organisms and thus play an important role in 
many lifestyle-related diseases such as arthritis, atherosclerosis, emphysema and 
cancer (Kehrer, 1993; Jacob, 1994; Halliwell et al., 1995).  
Lignin is an effective free radical scavenger because it stabilizes the reactions 
induced by oxygen and its radical species (Dizhbite et al., 2004; Sakagami et al., 
1992). Lignin is also known as a major component in dietary fibre which can inhibit 
the activity of enzymes related to generation of superoxide anion radicals and 
obstruct the growth and viability of cancer cells (Lu et al., 1998). Therefore, due to 
its antioxidant activity and capacity to reduce the production of radicals and its 
ability to stabilize reactions induced by oxygen and its radical species, the 
application of lignin in cosmetic, pharmaceutical and food processing industries is 
promising. 
 Pan et al. (2006) investigated the radical scavenging activity of lignin, 
identifying the most important structural features of the lignin for its antiradical 
efficiency. This study found that the processing conditions used for the extraction of 
organosolv ethanol lignin influenced the structural features such as functional groups 
and molecular weight of the isolated lignin and consequently the antioxidant activity 
of lignin. In general, lignin prepared at elevated temperature, extended reaction time, 
increased catalyst and diluted ethanol showed higher antioxidant activity due to an 
increase in the number of phenolic hydroxyl groups, low molecular weight and 
narrow polydispersity of the lignin. The antioxidant activity and structural features of 
the lignin can be predicted using the regression models developed (Pan et al., 2006). 
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 Besides, the antioxidant capacity of the lignin extracted from oil palm black 
liquor has been studied by Bhat et al. (2009). The antioxidant activity was 
characterized using 1,1-diphenyl-2-picrylhydrazyl (DPPH) as a reactive free radical 
method which has been widely recognized as the most reliable technique for 
measuring antioxidant activity (Senba et al., 1999; Dizhbite et al., 2004). The results 
on the percentage inhibition of DPPH radical in the isolated oil palm black liquor 
lignin were comparable to the earlier reports on lignin extracted from other plant 
sources (Vinardell et al., 2008; Ugartondo et al., 2008). Therefore, the results 
definitely showed that lignin obtained from oil palm waste has wide potential for use 
as an antioxidant compound and its use should be explored commercially (Bhat et 
al., 2009).  
The development of oil palm EFB lignin for its application in 
pharmaceuticals and food industries promises an additional value to lignin. However, 
before oil palm EFB lignin can be developed as a nutraceutical and health 
supplement, the investigation of its potential in interacting with other drugs or 
pharmaceutical agents must be carried out to ensure product safety. This is because 
many dietary polyphenolic compounds undergo extensive biotransformation 
including oxidation, reduction, methylation, sulfation, glucuronidation and microbial 
degradation (Lambert and Yang, 2003; Hu et al., 2003). Therefore, oil palm EFB 
lignin which is composed of polyphenol compounds would have the potential to be 
metabolized by the same drug metabolism enzymes (DMEs) as other drugs or 
pharmaceutical agents.  
In addition, the effect of plant extract on glutathione S-transferase (GST) 
activities (one of the phase II drug metabolism enzymes) was always investigated 
along with their antioxidant capacities, since the GST enzymes account for the 
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defence against oxidative stress. They detoxify endogenous harmful compounds such 
as the breakdown products of lipid peroxidation or DNA hydroperoxides (Hayes and 
Pulford, 1995; Nordberg and Arn’er, 2001). Another reason, to attract the interest on 
GST activity is the ability of resistant tumor cells to promote GST catalysed GSH 
conjugation of the pharmacologically active compounds such as antitumor drugs 
(Guadiano et al., 2000; van Zanden et al., 2004). In this respect, inhibitory effects of 
antioxidant on phase II enzymes such as GST activity are continuously investigated 
by researchers (Gyamfi et al., 2004). 
There are two general categories of drug interaction mechanisms namely 
pharmacokinetics which includes absorption, distribution, metabolism and excretion 
of drug and pharmacodynamics which includes the combination of pharmacological 
effects of a drug (Ismail, 2009). Many of these interactions involved inhibition of 
metabolizing enzymes resulting in increased systemic exposure and subsequent 
adverse drug reaction. In other cases, induction of metabolizing enzymes resulted in 
reduced systemic exposure leading to the risk of loss of efficacy of co-administered 
drugs (Zhang et al., 2010). Contrary to inhibition, induction of drug metabolizing 
enzyme activity is a slow process because it depends on the rate of synthesis of the 
new enzyme and is usually noticeable after a few days or weeks (Cott, 2001). The 
interaction could result in food-drug interaction and may cause adverse side effects 
(Honig et al., 1993; Sorensen, 2002; Brandin et al., 2007).  
 
2.4 Drug metabolizing enzymes   
 Drug metabolizing enzymes (DMEs) are a diverse group of proteins that are 
responsible for metabolizing a vast array of xenobiotic chemicals, including drugs, 
carcinogens, pesticides, pollutants and food toxicants, as well as endogenous 
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compounds, such as steroids, prostaglandins and bile acids (Coon, 2005; Brown et 
al., 2008; Rendic and Guengerich, 2010). Generally DMEs eliminate foreign 
compounds (xenobiotics) and endogenous substances by increasing solubility 
through the functionalization process in phase I and/or conjugation reactions in 
phase II.  
In phase I drug metabolism, the reaction includes transformation of a parent 
compound to more polar metabolites by unmasking functional groups such as 
hydroxyl (–OH), amine (–NH2) and sulfhydryl (–SH). The N- and O-dealkylation, 
aliphatic and aromatic hydroxylation, N- and S-oxidation and deamination are 
included in this reaction (Gonzalez and Tukey, 2005). In this phase, cytochrome 
P450 (CYP450) is the main enzyme performing mainly hydroxylation, hence acting 
as monooxygenases, dioxygenases and hydrolases (Gonzalez and Tukey, 2005). The 
addition of functional groups does little to increase the water solubility of the drug, 
but can dramatically alter the biological properties of the drug (Gonzalez and Tukey, 
2005). The main function of phase I metabolism is to prepare the foreign compounds 
for phase II metabolism (Gibson and Skett 2001; Nassar, 2009).  
Phase II drug metabolism reactions include conjugation reaction such as 
glucuronidation, sulfation, methylation, acetylation, glutathione and amino acid 
conjugation (Gonzalez and Tukey, 2005). Phase II metabolism enzymes are mostly 
transferases including UDP-glucuronosyltransferases (UGTs), sulfotransferases 
(SULTs), N-acetyltransferases (NATs), glutathione S-transferases (GSTs) and 
various methyltransferases mainly thiopurine S-methyltransferase (TPMT) and 
catechol O-methyl transferase (COMT) (Jancova et al., 2010).  
Although the phase II reactions are so named due to their sequence of 
occurring following phase I modifications of a drug, a xenobiotic can undergo phase 
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II metabolism without prior phase I metabolism if the foreign compound has already 
possessed suitable functional groups and therefore can be directly metabolized 
through phase II enzymes before being eliminated from the body (Kaushik et al., 
2006; Chen, 2012). Zidovudine, morphine and codeine are example of drugs which 
are metabolized primarily through UGT enzymes. The cancer chemotherapy agents 
such as adriamycin and thiotepa are the example of drugs which are metabolized 
primarily through GST enzyme (William et al., 2004; Scott and Kelly, 2003a; Scott 
and Kelly, 2003b; Akhdar et al., 2012). 
Metabolites formed from phase II reactions have higher polarity compared to 
the parent drugs, thus are more readily excreted in the urine and bile. Therefore, 
phase II is the true ‘detoxification’ of foreign compounds to produce metabolites that 
are generally water-soluble and easily excreted (Lohr et al., 1998). These enzymes 
mostly exhibit broad substrate selectivity and eliminate many therapeutic drugs, 
endogenous compounds and secondary plant metabolites such as flavonoids and 
polyphenolic compounds (Nijveldt et al., 2001). 
 
2.5 UDP-glucuronosyltransferase enzymes activity 
The uridine 5’–diphospho-glucuronosyltransferases (UGTs) are a 
superfamily of protein enzymes which are responsible for metabolism of xenobiotics 
such as drugs, chemical carcinogens, environmental pollutants and dietary 
substances and endobiotics such as bilirubin, steroid hormones, thyroid hormones, 
bile acids and fat-soluble vitamins (Kiang et al., 2005; Jancova et al, 2010). The 
UGT enzymes play a major role in catalyzing a conjugation process known as 
glucuronidation (Jancova et al., 2010).  
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Figure 2.4 illustrates the conjugation reaction scheme of nucleophile 
substrate with uridine-5’-diphospho-α-D-glucuronic acid (UDPGA). During the 
glucuronidation conjugation reaction a glucose-derived moiety glucuronic acid is 
conjugated to a suitable functional site (hydroxyl, carboxyl, carbonyl, sulfhydryl and 
amine) on a substrate modulated by UGT proteins. Generally, this reaction leads to 
formation of the respective β-D-glucuronides with easy elimination by bile or urine 
(Jancova et al., 2010). 
In mammalian cells, UGT superfamily can be divided into four families 
namely UGT1, UGT2, UGT3 and UGT8 (Mackenzie et al., 1997). However, two of 
the families are known to use UDPGA as sugar donors which are UGT1 (1A1, 1A3, 
1A4, 1A5, 1A6, 1A7, 1A8, 1A9, 1A10) and UGT2 (2A1, 2A3 2B4, 2B7, 2B11, 
2B15, 2B2) (Court et al., 2002). However, UGT1A1, 1A3, 1A4, 1A6, 1A9, 2B7 and 
2B15 appear to have the greatest importance in drug and xenobiotic metabolism 
(Kiang et al., 2005; Miners et al., 2010). Characterization of these isoforms based on 
substrate specificity is essential to understand their role in drug metabolism. In the 
drug metabolizing enzyme assay it is important to select suitable substrates which 
are specific to the enzyme for prediction of drug metabolic clearance (Miners and 
Birkett, 1998).  
 
 
 
 
 
 
22 
 
 
 
 
 
          
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.4: Conjugation of a nucleophilic substrate with uridine 5’-diphospho-α-D-
glucuronic acid (UDPGA), X is define as hydroxyl, carboxyl, carbonyl, sulfhydryl or amine 
(adopted from Rowland et al., 2013). 
   
 
In this study, 4-methylumbelliferone (4-MU) and p-nitrophenol (p-NP) were 
chosen as the probe substrates for UGT enzymes activity. p-NP is a synthetic 
chemical which is used as a starting material for pharmaceutical products, dyes and 
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as a fungicide (Eichenbaum et al., 2009). It appears as colourless to slightly yellow 
crystalline solid with no odour. The p-NP is excreted almost exclusively as its 
glucuronide and sulfate conjugates (Almási et al., 2011). Because of its simple and 
well characterized metabolic profile, p-NP is widely used as a model substrate to 
evaluate the effect of drug therapy, disease, nutrient deficiencies and other 
physiologically altered conditions on conjugative drug metabolism in animal studies 
both in vitro and in vivo (Almási et al., 2006).  
p-NP is commonly used because its colour disappearance upon 
glucuronidation can be followed by a colorimetric procedure (Bock et al., 1983; 
Embola et al., 2002). Conjugated p-NP is colourless and does not contribute to the 
colour output. Thus, the signal generated is inversely correlated with UGT activity 
present in the sample. This colour-changing property makes this compound useful as 
a marker substrate for studying UGT activity (Bock et al., 1983; Embola et al., 
2002).  
4-MU is a phenolic compound that is used as a drug in bile therapy. It is a 
crystalline solid and soluble in methanol and glacial acetic acid (Uchaipichat et al, 
2004). It is used as a standard for the fluorometric determination of enzyme activity 
(Uchaipichat et al, 2004). Both p-NP and 4-MU are known as planar phenol 
derivatives. These compounds have been reported to be mainly conjugated by 
UGT1A6 isoform in mammals although the contribution ratio differed extensively 
among the animal species (Mackenzie et al., 1997; de Wildt et al., 1999). However, 
some studies had reported that p-NP and 4-MU were also metabolized by multiple 
recombinant human UGT isoforms (Tsoutsikous et al. 2004; Uchaipichat et al., 
2004). Meanwhile, Yu et al. (2006) reported that recombinant rat UGT1A1, 
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UGT1A2, UGT1A3 and UGT1A7 isoforms showed glucuronidation activity towards 
4-MU.  
 
2.6 Glutathione S-transferase enzymes activity 
Glutathione S-transferase (GST) is one of the major phase II detoxification 
enzymes. GST activity is present in most animal tissues. GST utilizes glutathione 
(GSH) to scavenge electrophilic xenobiotics as part of an organism’s defence 
mechanism against the mutagenic, carcinogenic and toxic effects of such 
compounds. This is because GST enzymes account for the defence against oxidative 
stress and they detoxify endogenous harmful compounds such as the breakdown 
products of lipid peroxidation or DNA hydroperoxides (Hayes and Pulford, 1995; 
Nordberg and Arnér, 2001). The general mechanism for the conjugation of 
glutathione with xenobiotic compounds catalyzed by glutathione S-transferase 
enzymes is shown in Figure 2.5. Generally, GST enzymes catalyze conjugation 
reactions between glutathione and an electrophile compound by the formation of a 
thioether. This reaction generally uses 1-chloro-2,4-dinitrobenzene (CDNB) as a 
substrate, which can react enzymatically or non-enzymatically with the nucleophile 
(Jancova, 2010). Hence, the kinetics of the thioether formation can be monitored 
over time and the activity can be calculated (Jancova, 2010). 
GST has been described by two distinct superfamilies. The first superfamily 
consists of soluble dimeric enzymes which are involved in biotransformation of toxic 
xenobiotics and endobiotics (Jancova et al, 2010). This soluble GST superfamily is 
subdivided into eight separate classes and designated to Alpha, Mu, Pi, Theta, Zeta, 
Sigma, Kappa and Omega (Jancova et al, 2010). This class is based on their gene 
sequence identity. These enzymes have been described mainly in cytoplasm but they 
